Heart Views, 2013 Background: In patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty, abciximab reduces major adverse cardiac events (MACE). Most clinical trials have studied mainly intravenous administration.
Mohammed Balghith +3 more
doaj
Primary Coronary Angioplasty in the Elderly [PDF]
, 2005 Introdução: A angioplastia primária é a terapêutica de reperfusão com melhores resultados no enfarte agudo do miocárdio (EAM). Este facto assume particular relevância na população acima dos 75 anos, em que o risco hemorrágico relacionado com a trombólise
Cacela, D +8 more
core
Fatal Hemorrhagic Transformation of Acute Cerebral Infarction After the Use of Abciximab [PDF]
, 2000 Raymond Tak Fai Cheung, David S.W. Ho
openalex +1 more source
Platelet Inhibition in Percutaneous Coronary Interventions [PDF]
, 2018 : Mechanical disruption of atherosclerotic plaques at the time of percutaneous coronary intervention (PCI) is a potent stimulus for arterial thrombosis.
Roffi, Marco, Wyss, Christophe
core
Delayed Profound Thrombocytopenia After c7E3 Fab (Abciximab) Therapy [PDF]
, 1998 Leigh Ann Jenkins +3 more
openalex +1 more source
Letter by Abdellaoui et al Regarding Article, “Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention” [PDF]
, 2009 M. Abdellaoui +2 more
openalex +1 more source
Effect of Glycoprotein IIb/IIIa Antagonist Abciximab on Monocyte-Platelet Aggregates and Tissue Factor Expression [PDF]
, 2003 Sabine Steiner +5 more
openalex +1 more source
Successful systemic thrombolysis for carotid stent thrombosis [PDF]
, 2002 Hamann, Gerhard F. +3 more
core +1 more source
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction [PDF]
, 2017 Recent clinical data show that the risk of coronary thrombosis after antiplatelet drugs withdrawal is much higher than that of surgical bleeding if they are continued.
Chassot, P.-G +2 more
core